Found: 49
Select item for more details and to access through your institution.
Optimal infused CD34<sup>+</sup> cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01165-w
- By:
- Publication type:
- Article
Gastrointestinal toxicities of proteasome inhibitor therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 7, p. 1, doi. 10.1007/s00432-024-05716-3
- By:
- Publication type:
- Article
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
- By:
- Publication type:
- Article
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00973-w
- By:
- Publication type:
- Article
ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies.
- Published in:
- Science Signaling, 2016, v. 9, n. 415, p. 1, doi. 10.1126/scisignal.aac4380
- By:
- Publication type:
- Article
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1944, doi. 10.1111/bjh.19384
- By:
- Publication type:
- Article
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 866, doi. 10.1111/bjh.18944
- By:
- Publication type:
- Article
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. e37, doi. 10.1111/bjh.18753
- By:
- Publication type:
- Article
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide‐based maintenance therapy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. e23, doi. 10.1111/bjh.17393
- By:
- Publication type:
- Article
Effect of initial treatment on health‐related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect<sup>®</sup> MM Registry.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 93, doi. 10.1111/bjh.17131
- By:
- Publication type:
- Article
Gene expression profiling predicts relapse‐free and overall survival in newly diagnosed myeloma patients treated with novel therapies.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 4, p. e115, doi. 10.1111/bjh.17344
- By:
- Publication type:
- Article
RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 1, p. 80, doi. 10.1111/bjh.14525
- By:
- Publication type:
- Article
Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1571, doi. 10.1002/ajh.27029
- By:
- Publication type:
- Article
Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. 719, doi. 10.1002/ajh.26536
- By:
- Publication type:
- Article
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E455, doi. 10.1002/ajh.26360
- By:
- Publication type:
- Article
A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E243, doi. 10.1002/ajh.26178
- By:
- Publication type:
- Article
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 9, p. 2325, doi. 10.1007/s00277-021-04534-8
- By:
- Publication type:
- Article
Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Lung Nodule in a Patient with Multiple Myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib–lenalidomide–dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 2, p. 190, doi. 10.1111/ejh.14214
- By:
- Publication type:
- Article
The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma.
- Published in:
- Therapeutic Advances in Hematology, 2020, v. 11, p. 1, doi. 10.1177/2040620720979813
- By:
- Publication type:
- Article
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 494, p. 1, doi. 10.1126/scitranslmed.aau9087
- By:
- Publication type:
- Article
The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the Connect® MM Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e336, doi. 10.1016/j.clml.2024.05.021
- By:
- Publication type:
- Article
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e171, doi. 10.1016/j.clml.2022.12.003
- By:
- Publication type:
- Article
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 2, p. 112, doi. 10.1016/j.clml.2022.11.008
- By:
- Publication type:
- Article
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S247, doi. 10.1016/j.clml.2018.07.146
- By:
- Publication type:
- Article
Quantitation of navtemadlin in human plasma and brain tissue by liquid chromatography–tandem mass spectrometry.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 11, p. 1, doi. 10.1002/bmc.5467
- By:
- Publication type:
- Article
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
- By:
- Publication type:
- Article
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
- By:
- Publication type:
- Article
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect<sup>®</sup> MM Registry.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4
- By:
- Publication type:
- Article
Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 10, p. 1, doi. 10.1038/s41408-020-00369-0
- By:
- Publication type:
- Article
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. E319, doi. 10.1002/ajh.25633
- By:
- Publication type:
- Article
Long‐term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. E72, doi. 10.1002/ajh.25375
- By:
- Publication type:
- Article
Melphalan‐based autologous transplant in octogenarian multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. E2, doi. 10.1002/ajh.25310
- By:
- Publication type:
- Article
Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3568, doi. 10.1002/cncr.30770
- By:
- Publication type:
- Article
The novel protein homeostatic modulator BTX306 is active in myeloma and overcomes bortezomib and lenalidomide resistance.
- Published in:
- Journal of Molecular Medicine, 2020, v. 98, n. 8, p. 1161, doi. 10.1007/s00109-020-01943-6
- By:
- Publication type:
- Article
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50880-2
- By:
- Publication type:
- Article
Acute Pancreatitis Associated with Ixazomib in a Multiple Myeloma Patient.
- Published in:
- Acta Haematologica, 2018, v. 139, n. 1, p. 67, doi. 10.1159/000484655
- By:
- Publication type:
- Article
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1663, doi. 10.1002/cncr.35171
- By:
- Publication type:
- Article
Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987
- By:
- Publication type:
- Article
Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 22, p. 4198, doi. 10.1002/cncr.33809
- By:
- Publication type:
- Article
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The role of bone‐modifying agents in myeloma bone disease.
- Published in:
- JBMR Plus, 2021, v. 5, n. 8, p. 1, doi. 10.1002/jbm4.10518
- By:
- Publication type:
- Article